Short answer
Dyne Therapeutics, Inc. (DYN) filed an 8-K current report with the SEC on May 11, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Quarterly financial results covered period ended March 31, 2026.
Dyne Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Quarterly financial results covered period ended March 31, 2026
- Press release furnished as Exhibit 99.1, containing the substantive financial results
- Information furnished rather than filed under Exchange Act Section 18 liability provisions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Dyne Therapeutics, Inc. 8-K filings
Get the next DYN 8-K as it lands
Follow DYN for push alerts, or ask the research agent what this filing means.